Argonde C. Van Harten

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Plasma Alzheimer Biomarkers and Diagnostic Decision-Making in Memory Clinics.

Plasma Alzheimer Biomarkers and Diagnostic Decision-Making in Memory Clinics.

Journal: JAMA network open

Published: August 13, 2026

Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment.

Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment.

Journal: Neurology

Published: August 10, 2026

Agreement between clinical diagnosis and blood biomarkers of Alzheimer's disease in a real-world peripheral memory clinic.

Agreement between clinical diagnosis and blood biomarkers of Alzheimer's disease in a real-world peripheral memory clinic.

Journal: Journal of Alzheimer's disease : JAD

Published: July 28, 2026

Longitudinal Change in Blood-Based Biomarkers and the Association With MRI-Measured Neurodegeneration in Cognitively Unimpaired Individuals.

Longitudinal Change in Blood-Based Biomarkers and the Association With MRI-Measured Neurodegeneration in Cognitively Unimpaired Individuals.

Journal: Neurology

Published: June 01, 2026

Analytical framing of Amyloid beta monoclonal antibody trials in Alzheimer's disease can obscure clinical effects.

Analytical framing of Amyloid beta monoclonal antibody trials in Alzheimer's disease can obscure clinical effects.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: May 10, 2026

Plasma biomarkers for Alzheimer disease: the road from laboratory results to clinical practice.

Plasma biomarkers for Alzheimer disease: the road from laboratory results to clinical practice.

Journal: Nature reviews. Neurology

Published: May 06, 2026

The ABOARD-RWD infrastructure: Using linked real-world data to study the diagnosis and management of dementia.

The ABOARD-RWD infrastructure: Using linked real-world data to study the diagnosis and management of dementia.

Journal: Journal of Alzheimer's disease : JAD

Published: March 30, 2026

Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline.

Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline.

Journal: Alzheimer's research & therapy

Published: January 12, 2026

Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline.

Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline.

Journal: JAMA network open

Published: December 03, 2025

Genomic analyses reveal new insights into Alzheimer's disease.

Genomic analyses reveal new insights into Alzheimer's disease.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

The relationship between cognitive domains and everyday functioning in Alzheimer's disease.

The relationship between cognitive domains and everyday functioning in Alzheimer's disease.

Journal: Neuropsychology

Published: October 16, 2025

The Clinical Applicability of Blood Biomarkers for Alzheimer's disease in the Memory Clinic

The Clinical Applicability of Blood Biomarkers for Alzheimer's disease in the Memory Clinic

Journal: Tijdschrift voor gerontologie en geriatrie

Published: September 15, 2025

Showing 1-12 of 88

Last Updated: 09/26/2026